← Human Trials & Peer-Reviewed Studies

Vitamin D Status and Longitudinal Changes in Body Composition in Patients with Chronic Obstructive Pulmonary Disease - A Prospective Observational Study.

Plain-language guide to PMID 38895044 (2024): observational study of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
38895044
Journal
International journal of chronic obstructive pulmonary disease
Year
2024
Study type
Observational Study
Authors
Minter M et al. (7 authors)
DOI
10.2147/COPD.S458102

What This Study Did, in Plain Language

What Was Tested

This observational study looks at Vitamin D, K2, Magnesium and Zinc.

This study aimed to evaluate the association between vitamin D levels and status with body composition (BC), as well as with its changes over time.

Multiple linear regression analyses were performed to assess the relationships between 25(OH)D (nmol/l) and longitudinal changes in BMI, fat-free mass index (FFMI), fat mas index (FMI) and bone mineral density (BMD).

Why It Was Studied

Alterations in body weight and composition are common in patients with chronic obstructive pulmonary disease (COPD) and are independent predictors for morbidity and mortality.

Low vitamin D status is also more prevalent in patients with COPD compared to controls and has been related to lower lung function, muscle atrophy and impaired musculoskeletal function.

Who Took Part

By PubMed's age tags, the people studied were middle-aged adults and older adults, both men and women.

Patients with COPD and controls without COPD, participating in the Individualized COPD Evaluation in relation to Ageing (ICE-Age) study, a prospective observational study, were included.

What Was Measured

The subject headings attached to it are Pulmonary Disease, Chronic Obstructive, Vitamin D, Bone Density, Vitamin D Deficiency, Body Composition, Absorptiometry, Photon and Lung.

The authors tagged it with the keywords bone mineral density, chronic obstructive pulmonary disease, fat-free mass and longitudinal changes.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2024 (International journal of chronic obstructive pulmonary disease), a journal based in New Zealand.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.